Prop 65 andro litigation
This article was originally published in The Tan Sheet
Executive Summary
Weider, MuscleTech, M.D. Labs, SportPharma reach settlements with state of California in ongoing Prop 65 case against androstenedione supplement marketers. Agreements, which include payments for "corrective advertising" programs, penalties and warnings, are similar to consent judgments approved in Oakland state court June 28 (1"The Tan Sheet" June 10, 2002, p. 12). Case management conference with remaining defendants, including Bodyonics, slated for Aug. 2; Judge Ronald Sabraw is considering holding mini-trial on whether andro is anabolic steroid...
You may also be interested in...
Prop 65 Andro Settlements Include “Corrective Advertising” Provision
Settling defendants in California's Prop 65 litigation against androstenedione supplement marketers would pay from $1,341 to $4,546 each to fund "corrective advertising" programs, according to proposed consent judgments filed in Oakland state court
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.